| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $213K | +35.2% |
| Cost of Revenue | $194K | +103.9% |
| Gross Profit | $19K | -69.3% |
| R&D Expense | $748K | -26.4% |
| SG&A Expense | $6.2M | -2.9% |
| Operating Income | -$7.7M | +20.0% |
| Interest Expense | $458K | -43.1% |
| Pre-tax Income | -$8.6M | +15.7% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $24K | -3.2% |
| Inventory | $225K | -34.4% |
| Current Assets | $8.9M | +163.2% |
| Total Assets | $11.2M | +81.7% |
| Current Liabilities | $1.3M | -16.2% |
| Total Liabilities | $1.4M | -67.1% |
| Stockholders' Equity | $9.9M | +384.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | -10.0% |
| Financing Cash Flow | $12.1M | +8602.0% |
| — |
| Net Income | -$8.6M | +15.7% |
| EPS (Diluted) | -$172.19 | +72.2% |